Recombinant CD38 (Daratumumab Biosimilar) 抗体
Quick Overview for Recombinant CD38 (Daratumumab Biosimilar) 抗体 (ABIN7581292)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
Expression System
- CHO Cells
-
原理
- Anti-CD38 Reference Antibody (daratumumab)
-
产品特性
- Anti-CD38 Reference Antibody (daratumumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.34 kDa.
-
纯度
- >95 %
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Conditions: Multiple Myeloma
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- CD38 (Daratumumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Synonyms: cADPr hydrolase 1, T10
-
分子量
- 145.34 kDa
-
UniProt
- P28907
抗原
-